Octreotide Injection
Last Updated: July 7, 2017
Status: Current
Octreotide Injection
Products Affected - Description
-
Octreotide Acetate injection, Fresenius Kabi
50 mcg/mL, 1 mL vial, 10 count (NDC 63323-0365-01)
Octreotide Acetate injection, Sagent
50 mcg/mL, 1 mL vial, 10 count (NDC 25021-0451-01)
Reason for the Shortage
-
- Fresenius Kabi did not provide a reason for the shortage.
- Mylan Institutional has octreotide available.
- Sagent has octreotide on shortage due to manufacturing delays.
- Sun Pharma refuses to provide availability information for any of their products including octreotide.
- Teva has octreotide available.
- Novartis has Sandostatin available.
Available Products
-
Sandostatin injection, Novartis
50 mcg/mL, 1 mL ampule, 10 count (NDC 00078-0180-01)
100 mcg/mL, 1 mL ampule, 10 count (NDC 00078-0181-01)
200 mcg/mL, 5 mL vial, 1 count (NDC 00078-0183-25)
500 mcg/mL, 1 mL ampule, 10 count (NDC 00078-0182-01)
1000 mcg/mL, 5 mL vial, 1 count (NDC 00078-0184-25)
Octreotide Acetate injection, Fresenius Kabi
100 mcg/mL, 1 mL vial, 10 count (NDC 63323-0376-01)
200 mcg/mL, 5 mL vial, 1 count (NDC 63323-0378-05)
500 mcg/mL, 1 mL vial, 10 count (NDC 63323-0377-01)
1000 mcg/mL, 5 mL vial, 1 count (NDC 63323-0379-05)
Octreotide Acetate injection, Mylan Institutional
50 mcg/mL, 1 mL syringe, 10 count (NDC 67457-0239-01)
100 mcg/mL, 1 mL syringe, 10 count (NDC 67457-0245-01)
500 mcg/mL, 1 mL syringe, 10 count (NDC 67457-0246-01)
Octreotide Acetate injection, Sagent
100 mcg/mL, 1 mL vial, 10 count (NDC 25021-0452-01)
200 mcg/mL, 5 mL vial, 1 count (NDC 25021-0454-05)
500 mcg/mL, 1 mL vial, 10 count (NDC 25021-0453-01)
200 mcg/mL, 5 mL vial, 1 count (NDC 25021-0454-05)
500 mcg/mL, 1 mL vial, 10 count (NDC 25021-0453-01)
1000 mcg/mL, 5 mL vial, 1 count (NDC 25021-0455-05)
Octreotide Acetate injection, Teva
50 mcg/mL, 1 mL vial, 25 count (NDC 00703-3301-04)
100 mcg/mL, 1 mL vial, 25 count (NDC 00703-3311-04)
200 mcg/mL, 5 mL vial, 1 count (NDC 00703-3333-01)
500 mcg/mL, 1 mL vial, 25 count (NDC 00703-3321-04)
1000 mcg/mL, 5 mL vial, 1 count (NDC 00703-3343-01)
Estimated Resupply Dates
-
- Fresenius Kabi has octreotide 50 mcg/mL 1 mL vials on back order and the company estimates a release date of 1st quarter 2018.
- Sagent has octreotide 50 mcg/mL 1 mL vials on back order and the company estimates a release date of July 2017.
Related Shortages
| Alcohol Dehydrated Injection (Ethanol) | Current |
| Allopurinol Injection | Resolved |
| Amifostine Injection | Resolved |
| Azathioprine Injection | Resolved No Longer Available No Commercially Available Preparations |
| Colchicine Tablets | Resolved |
| Dexrazoxane Injection | Current |
| Drotrecogin Alfa (Activated) Injection | No Longer Available |
| Foscarnet Injection | Resolved |
| Leucovorin Calcium Injection | Current |
| Levocarnitine Injection | Resolved |
| Levocarnitine Oral Tablets and Solution | Current |
| Mechlorethamine Hydrochloride Injection | Resolved |
| Metyrosine Capsules | Resolved |
| Phenylephrine 2.5% and 10% Ophthalmic Solution | Resolved |
| Sodium Fluoride Oral Drops | Resolved |
| Surgical Lubricant | Resolved |
| Tiopronin Tablets | Resolved |
| Trace Elements Injection | Current |
| Zinc Injection | Resolved |
Updated
July 7, June 14, May 5, April 4, March 24, 21 and 13, February 21, January 6, 2017; December 9, November 21 and 10, October 5, August 25, 18 and 5, July 14, June 28, May 27, 20 and 17, April 14 and 13, March 16, 2016, University of Utah, Drug Information Service. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.
